WELL Health Technologies (TSE:WELL) Price Target Raised to C$8.50

WELL Health Technologies (TSE:WELL) had its price objective raised by Royal Bank of Canada from C$7.00 to C$8.50 in a research report sent to investors on Tuesday,BayStreet.CA reports.

Several other equities analysts have also weighed in on the stock. TD Securities upped their price objective on shares of WELL Health Technologies from C$8.00 to C$8.50 in a report on Tuesday, December 17th. Ventum Financial decreased their price objective on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating for the company in a report on Tuesday, October 29th. Haywood Securities upped their target price on WELL Health Technologies from C$8.00 to C$10.00 in a research report on Friday, December 13th. Raymond James boosted their price target on shares of WELL Health Technologies from C$10.00 to C$11.00 in a research note on Tuesday, December 17th. Finally, CIBC raised their price objective on shares of WELL Health Technologies from C$5.25 to C$7.00 in a research note on Friday, December 13th.

WELL Health Technologies Stock Performance

Shares of WELL stock opened at C$6.84 on Tuesday. The firm has a 50 day moving average of C$6.09 and a 200-day moving average of C$5.09. The company has a market cap of C$1.70 billion, a price-to-earnings ratio of 12.00, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20. The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57. WELL Health Technologies has a 52 week low of C$3.41 and a 52 week high of C$7.36.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.